BioSpace News Archive

Fred Hutchinson Cancer Research Center to present updated interim data from ongoing MB-106 Phase 1/2 clinical trial

SOHM, Inc. to take advantage of the FDA converting more prescription Products to the over-the-counter Markets.

Moffitt Cancer Center is honored to earn the No. 3 position on DiversityInc’s Top Hospitals and Health Systems for 2021.

Grady Memorial Hospital’s Marcus Trauma Center has again earned the highest national trauma recognition — Level I Trauma Center, verified by the American College of Surgeons.

MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity,

Laevoroc Oncology (‘Laevoroc’ or ‘the company’), a privately owned, Swiss oncology development group of companies, launched today announcing successful completion of seed financing with private and individual investors, raising over USD 1.1 million.

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today reported financial results for its fiscal first quarter 2021 and provided an overview of recent progress and accomplishments.

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced financial results for the first quarter ended March 31, 2021, as well as business highlights.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today reported financial results and recent business highlights for the quarter ended March 31, 2021.

Aruvant Sciences (“Aruvant”), a private company focused on developing gene therapies for rare diseases, today announced the selection of an abstract for presentation at the European Hematology Association (EHA) Virtual Congress which will take place June 9 to 17, 2021.